The Pozzidency of Donald J. Trump: Typhoid Donnie's Slow Hypoxic Demise **Sweat Thread** (updated 100x/minute)

https://twitter.com/JohnJHarwood/status/1312217531856322560

https://twitter.com/brithume/status/1265045009323241472

2 Likes

https://twitter.com/kaitlancollins/status/1312235842480467968?s=21

First that experimental drug cocktail and now Remdesivir. Part of me suspects Trump really has a “what have you got to lose” philosophy when it comes to medications. I think he’s probably pushing the doctors to be aggressive with his treatment, even though aggressive therapy may not be productive.

5 Likes

I don’t think Trump taking remdesivir is an indication that his case is critical. The president is going to get anything that increases his odds of surviving.

He deserves hydroxychloraquine and bleach. Medical ethics sucks for not having a good solution to this problem. We need our own Herold Shipman.

1 Like

That I’m not as sure on. We had access to plasma before that and I’m no longer in a position we’re I’m involved in that situation. I just admit and move on these days. Before in the dark times was helping run a makeshift icu in an er

https://twitter.com/jaketapper/status/1312238289500418051

6 Likes

The whole time?!

Trump campaign manager is the modern version of Spinal Tap drummer.

21 Likes

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32021-3/fulltext?fbclid=IwAR3hUfj-Ngdhy6jNnAzHSL6JaBVIdP_xmrib0WTbJTf9ZLPk_XCQVGPNuH4

In the first published placebo-controlled trial of remdesivir for treating severe COVID-19, Yeming Wang and colleagues were unable to attain their primary endpoint of time to clinical improvement. Although admittedly underpowered due to early trial termination, remdesivir did not appear to affect rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA load decline and mortality when compared with placebo. Given these disappointing findings, we are left to wonder if a lack of clinically significant outcomes in placebo-controlled trials could have been predicted. By inhibiting early coronavirus life cycle in vitro and in animal models remdesivir might require initiation before the peak viral replication, which is not feasible in the clinical human presentation of COVID-19.

1 Like

(ponied bad)

Dropping like flies. With this many positives, the likelihood of a bad outcome for somebody has to be going up.

1 Like

The rules fly out of the window for POTUS anyway.

2 Likes

I feel bad for the first time in this saga because it isn’t ok to be happy that a treatment is ineffectual. And yet.

I did not have ACB coming in like the angel of death and leaving ruins in her wake on my bingo card.

3 Likes

Yes you did, just after she was confirmed.

12 Likes

1 Like

CNN is actually coming through with all kinds of good info right now. Lemon is so good.

1 Like

Saying that respiratory failure is an adverse effect of covid patients taking the drug feels like a misunderstanding between correlation and causation.

1 Like

1 Like